The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

U.S. drug maker Eli Lilly & Co. is slashing the prices of its popular diabetes and weight-loss drugs Mounjaro and Zepbound by ...

Ozempic for weight loss in India explained, price, benefits, side effects, health risks and expert opinion on whether ...

I ordered Mounjaro, one of the so-called 'miracle' weight-loss injections that have been dominating headlines. Within weeks, ...

While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...

A medical expert warned of the side effects of the newly launched weight loss drug and advised that the drug should be taken ...

Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the ...

Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at INR 8,800 a month or four ...

Ozempic can be beneficial for a lot of people, however, some people should avoid it. Read on to know why the drug is not for ...

Ozempic (injectable semaglutide) is a once-weekly treatment indicated as an add-on to diet and exercise for adults with uncontrolled Type 2 diabetes mellitus (T2DM).

But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to Mounjaro, Eli Lilly’s blockbuster that has become India’s top-selling drug ...